These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 4393358

  • 1. [Action of ouabain on the arrhythmic effect of catecholamines].
    Mukaoara K.
    Nihon Yakurigaku Zasshi; 1970; 66(1):36-44. PubMed ID: 4393358
    [No Abstract] [Full Text] [Related]

  • 2. Adrenergic contribution to digitalis action.
    Tanabe T, Shudo I, Saito H.
    Proc West Pharmacol Soc; 1975; 18():20-2. PubMed ID: 241087
    [No Abstract] [Full Text] [Related]

  • 3. Effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) in experimental chloroform-epinephrine and digitalis dysrhythmias.
    Melville KI, Eu HY, Berger JM, Dookhoo A.
    J Pharmacol Exp Ther; 1970 Oct; 175(1):147-56. PubMed ID: 5528538
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antiarrhythmic effect of some naphthylalkylamine derivatives.
    Hadházy P, Kecskeméti V, Vizi ES, Illés P.
    Acta Physiol Acad Sci Hung; 1968 Oct; 33(2):185-95. PubMed ID: 5679793
    [No Abstract] [Full Text] [Related]

  • 14. Glucagon-induced cardiac effects following normal and toxic doses of ouabain.
    Denney DL, Daniell HB.
    Arch Int Pharmacodyn Ther; 1971 May; 191(1):111-9. PubMed ID: 5557388
    [No Abstract] [Full Text] [Related]

  • 15. [Drug interactions between cardiac glycosides and beta-sympathomimetics].
    Greeff K, Köhler E, Fortmüller HW, Schmidt R.
    Arzneimittelforschung; 1973 Jun; 23(6):759-64. PubMed ID: 4740757
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Sensitization to metabolic and cardiovascular effects of catecholamines].
    Leblanc J, Vallière J, Vachon C.
    J Physiol (Paris); 1972 Oct; 65():Suppl:255A. PubMed ID: 4649937
    [No Abstract] [Full Text] [Related]

  • 18. Central beta-adrenoceptor sites and ouabain action.
    Saxena PR, Bhargava KP.
    Pharmacol Res Commun; 1974 Aug; 6(4):347-55. PubMed ID: 4373769
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of the peak inotropic effects of a catecholamine and a digitalis glycoside in the intact canine heart.
    Beiser GD, Epstein SE, Goldstein RE, Stampfer M, Braunwald E.
    Circulation; 1970 Nov; 42(5):805-13. PubMed ID: 5477254
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.